The Patent Finder
US

Lipid Nanoparticle Compositions and Methods for mRNA Delivery

US 10,413,618 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jun 8, 2032 · Low confidence

Filed Dec 26, 2018 as application 16/233,031 · Granted Sep 17, 2019
Base term, 20 years from filing
Today
20 years from filing
2012 2032
Clock starts
Jun 8, 2012
Term ends
Jun 8, 2032
Granted
Sep 17, 2019
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,350,303, to Jun 8, 2032. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
25
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 8, 2012, when application PCT/US2012/041724, the earliest non-provisional in its chain, was filed (this one was filed Dec 26, 2018); a parent in its chain could not be resolved (the next row)Jun 8, 2032High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,350,303)resolves to Jun 8, 2032, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Further caveats on recordThe record names parents not resolved: 15482117Low confidence overallLow confidence
Computed term endThe steps above, in orderJun 8, 2032Low confidence

This family

Application PCT/US2012/041724PCT application
no patent term
no patent term
Application 14/124,608Abandoned
not computed
not computed
US 9,308,281In force
no later than Jun 2032
no later than Jun 2032
US 9,597,413In force
no later than Jun 2032
no later than Jun 2032
US 10,238,754In force
no later than Jun 2032
no later than Jun 2032
US 10,413,618this patent
Jun 2032
Jun 2032
US 10,350,303In force
Jun 2032
Jun 2032
US 10,507,249In force
Jun 2032
Jun 2032
8 of 25 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 25, 2019
Reel 48427, frame 678
Guild, Braydon Charles; Derosa, Frank; Heartlein, MichaelShire Human Genetic Therapies, Inc.Assignment of Assignor's Interest
Feb 25, 2019
Reel 48429, frame 359
Shire Human Genetic Therapies, Inc.Rana Therapeutics, Inc.Assignment of Assignor's Interest
Feb 25, 2019
Reel 48429, frame 750
Rana Therapeutics, Inc.Translate Bio, Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited